文献速递脑血管病神经重症与神经感染

强化降压与深部脑出血血肿周围水肿扩张的关系

Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2019-07-05

本研究为ATACH-2随机试验的探索性分析,纳入870例幕上深部脑出血患者,其中780例有神经影像数据。结果显示强化降压与24小时血肿周围水肿扩张率(PHER)降低相关,PHER仅在基底节出血中与不良预后相关,而在丘脑出血中无独立关联。

要点

  • 强化降压与深部脑出血24小时PHER降低独立相关。
  • PHER与不良预后在全深部出血中无独立关联,但受出血部位修饰。
  • 基底节出血中PHER与3个月不良预后相关,丘脑出血中无此关联。

核心结论

  • 强化降压与深部脑出血24小时血肿周围水肿扩张率降低相关。
  • PHER在全深部脑出血中与预后无独立关联,但在基底节出血中与不良预后相关。

研究设计与样本

  • ATACH-2随机试验的探索性分析,纳入幕上深部脑出血患者。
  • 870例中780例(90%)有神经影像数据,包括336例丘脑出血和444例基底节出血。

主要发现

  • 强化降压与PHER降低在单变量分析中相关(β=-0.15;95%CI -0.26至-0.05;P=0.007)。
  • 多变量分析中强化降压与PHER降低仍相关(β=-0.12;95%CI -0.21至-0.02;P=0.03)。
  • PHER与全深部出血不良预后无独立关联(OR 1.14;95%CI 0.93-1.41;P=0.20)。
  • 部位修饰效应显著(多变量交互P=0.02):基底节出血中PHER与不良预后相关(OR 1.42;95%CI 1.05-1.97;P=0.03),丘脑出血中无关联(OR 1.02;95%CI 0.74-1.40;P=0.89)。

临床怎么用

  • 对深部脑出血患者,强化降压可能有助于减缓血肿周围水肿扩张。
  • 在基底节出血中,PHER可作为临床试验的潜在终点指标。

局限性

  • 本研究为探索性分析,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- It is unknown whether blood pressure (BP) reduction influences secondary brain injury in spontaneous intracerebral hemorrhage (ICH). We tested the hypothesis that intensive BP reduction is associated with decreased perihematomal edema expansion rate (PHER) in deep ICH. Methods- We performed an exploratory analysis of the ATACH-2 randomized trial (Antihypertensive Treatment of Acute Cerebral Hemorrhage-2). Patients with deep, supratentorial ICH were included. PHER was calculated as the difference in perihematomal edema volume between baseline and 24-hour computed tomography scans divided by hours between scans. We used regression analyses to determine whether intensive BP reduction was associated with PHER and if PHER was associated with poor outcome (3-month modified Rankin Scale score 4-6). We then used interaction analyses to test whether specific deep location (basal ganglia versus thalamus) modified these associations. Results- Among 1000 patients enrolled in ATACH-2, 870 (87%) had supratentorial, deep ICH. Of these, 780 (90%) had neuroimaging data (336 thalamic and 444 basal ganglia hemorrhages). Baseline characteristics of the treatment groups remained balanced (P>0.2). Intensive BP reduction was associated with a decrease in PHER in univariable (β= -0.15; 95% CI, -0.26 to -0.05; P=0.007) and multivariable (β=-0.12; 95% CI, -0.21 to -0.02; P=0.03) analyses. PHER was not independently associated with outcome in all deep ICH (odds ratio, 1.14; 95% CI, 0.93-1.41; P=0.20), but this association was modified by the specific deep location involved (multivariable interaction P=0.02); in adjusted analyses, PHER was associated with poor outcome in basal ganglia (odds ratio, 1.42; 1.05-1.97; P=0.03) but not thalamic (odds ratio, 1.02; 95% CI, 0.74-1.40; P=0.89) ICH. Conclusions- Intensive BP reduction was associated with decreased 24-hour PHER in deep ICH. PHER was not independently associated with outcome in all deep ICH but was associated with poor outcome in basal ganglia ICH. PHER may be a clinically relevant end point for clinical trials in basal ganglia ICH.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Leasure AC, Qureshi AI, Murthy SB, et al. Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage. Stroke. 2019. PMID: 31272326. doi:10.1161/STROKEAHA.119.024838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。